Australia Therapeutic G…
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for se…
Gilead Sciences Announc…
Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug applic…
Pfizer and BioNTech Ini…
Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the safety, tolerability and …
Stempeutics gets DCGI n…
Stempeutics, a group company of Manipal Education and Medical Group (MEMG) said it has received DCGI clearance to …
Pfizer Shares In Vitro …
Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the act…
FDA may permit Pfizer C…
Dr Anthony Fauci, the chief medical advisor to the White House has gone on to confirm that FDA might as well appro…
Abzena appoints Jim Ken…
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to c…
Indian Pharmaceutical I…
It shouldn’t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian …
19th Edition of BioAsia…
19th edition of the Asia’s largest life-sciences and Health Tech forum BioAsia, the annual flagship event of Gover…
Genezen appoints Senior…
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early…
Fermenta Biotech Limite…
Fermenta Biotech Limited announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Service…
Ashfield Engage bolster…
Ashfield Engage, part of UDG Healthcare, has announced the acquisition of Medaxis, a patient engagement services p…
